Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 3 2Phase NA 1Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Prolactinoma 2Polycystic Ovary Syndrome 2Recurrence 1Pituitary Neoplasms 1Ovarian Hyperstimulation Syndrome 1

Interventions

Proton Therapy 2Propofol 2Hydrocortisone 2Desflurane 2parecoxib 1loxoprofen 1Yoga 1Transcranial Magnetic Stimulation 1Tramadol 1Surgical Procedures, Operative 1Supine Position 1Sevoflurane 1Saline Solution 1Rosiglitazone 1Resistance Training 1Radiation Dose Hypofractionation 1Protons 1Positron-Emission Tomography 1Octreotide 1Neurosurgical Procedures 1Neuropsychological Tests 1Nasal Lavage 1Human Growth Hormone 1Endoscopic Mucosal Resection 1Early Intervention, Educational 1Dexamethasone 1Deamino Arginine Vasopressin 1Cabergoline 1Bromocriptine 1Bed Rest 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Pituitary Neoplasms × Cabergoline × Clear all
NCT03457389 2020-03-18

Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma

Seoul National University Hospital

Phase NA Unknown
68 enrolled
Endocrine

Pituitary Neoplasms, Recurrence, Prolactinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡